Sanj K Patel Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

KNSA Quotes by TradingView

Sanj K Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 63,012 shares of KNSA, which is worth approximately $1.2 Million. The most recent transaction as insider was on Feb 08, 2021, when has been sold 4,924 shares (Class A Common Shares) at a price of $1.59 per share, resulting in proceeds of $7,829. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63K
10.36% 3M change
48.01% 12M change
Total Value Held $1.2 Million

Sanj K Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2021
BUY
Exercise of conversion of derivative security
$7,829 $1.59 p/Share
4,924 Added 50.0%
4,924 Class A Common Shares
Oct 12 2020
SELL
Open market or private sale
$3,167,714 $21.02 p/Share
150,700 Reduced 100.0%
0 Class A Common Shares
Oct 12 2020
BUY
Exercise of conversion of derivative security
$239,613 $1.59 p/Share
150,700 Added 50.0%
150,700 Class A Common Shares
Oct 09 2020
SELL
Open market or private sale
$18,312 $21.0 p/Share
872 Reduced 100.0%
0 Class A Common Shares
Oct 09 2020
BUY
Exercise of conversion of derivative security
$1,386 $1.59 p/Share
872 Added 50.0%
872 Class A Common Shares
SKP

Sanj K Patel

CHAIRMAN & CEO
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KNSA